Chapter 4 Coxiella burnetii

Similar documents
Chapter 23 Lassa virus. Lassa virus is a RNA virus belonging to the family of Arenaviridae. As the causative agent of

Bacillus anthracis. Summary Data

Chapter 3 Campylobacter jejuni and Campylobacter coli

Chapter X. Campylobacter jejuni and Campylobacter coli

Q Fever What men and women on the land need to know

Effect of Host Species on the Dose Response of Inhaled Bacillus anthracis Spores

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Q FEVER Australian and global perspectives including the recent Netherlands outbreak

Yersinia pestis. Yersinia and plague. Dr. Hala Al Daghistani

QMRA in the Built Environment

Anthrax: An Epidemiologic Perspective. Denise Dietz Public Health Epidemiologist

Q Fever. Coxiella Burnetii. (Also Known as Query Fever) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS

Q Fever Guidance Document NASPHV/NASAHO

Disease Transmission Methods

Medical Bacteriology - Lecture 7. Spore- forming Gram Positive Rods. Bacillus

FDA-iRISK A Comparative Risk Assessment System for Evaluating and Ranking Food-Hazard Pairs: Case Studies on Microbial Hazards

(b) Describe the role of antigen presentation in the body s specific immune response to infection by viruses. (4)

Q FEVER. By Theresa Deike. Disease Etiologic Agent. Disease Transmission and Reservoirs

Annual Epidemiological Report

Q FEVER: what the meat industry needs to know. Prof Stephen R. Graves Medical Director, Australian Rickettsial Reference Laboratory

ALAT - Chapter 4. Occupational Health and Safety. Dr. Carrie Freed, DACLAM, DVM, MLAS

Dr.Baha,Hamdi AL-Amiedi Ph. D.Microbiology

Characteristics of Mycobacterium

Q-FEVER Q FEVER. CPMP/4048/01, rev. 3 1/7 EMEA 2002

Francisella tularensis. Patricia Bolivar MS., CLS, PHM

Chapter 24 The Immune System

Boston MRC Introduction to Biological Hazards Response

Microbiological Risk Assessment Review of B. cereus

DISEASE DETECTIVES PRACTICE ACTIVITIES

1918 Influenza; Influenza A, H1N1. Basic agent information. Section I- Infectious Agent. Section II- Dissemination

C for 2 hr at 22,620 X G. The supernatant fluid. was discarded and the sediment resuspended to

Dengue Virus-Danger from Deadly Little Dragon

Dose response relationships for Listeria monocytogenes in ready-to-eat foods

The Chain of Infection

Overview of 2015 Zoonoses Data

Foundations in Microbiology

Pathogens: Microorganisms that are capable of causing disease Infection: Results when a pathogen invades and begins growing within the host Disease:

Chapter 6- An Introduction to Viruses*

Meteorology and infectious diseases: a risk for public health?

Chapter 13. Topics - Human Host - Progress of an Infection - Epidemiology

Brachyspira & Lawsonia

Health care workers and infectious diseases

Listeria monocytogenes Risk Assessment: Executive Summary

Histoplasmosis. Disease Etiology: Disease Transmission: Reservoirs: Specific Microbial Characteristics: By: Ernest Aguilar

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

Coxiella burnetii, S.aureus and Mycobacterium in the GI tract. By :Nader Alaridah MD, PhD

Q Fever Herd Management Plan

DU de thérapeutiques anti-infectieuses. Coxiella burnetii. Pierre-Edouard Fournier. Grenoble, 19 janvier 2018

2014 Pearson Education, Inc. CHAPTER 14 Infection, Infectious Diseases, and Epidemiology

Salmonella Enteritidis: Surveillance Data and Policy Implications

Q Fever among Dairy Cattle in Chiang Mai Province, Thailand, 2012: A Preliminary Study

NIAID Biodefense Research Agenda for Category B and C Priority Pathogens

ANSI/ASHRAE Standard Legionellosis: Risk Management for Building Water Systems

Exposures to: Mold, Mildew, and Metalworking Fluids

A BSL-1 lab houses activities that require only standard microbial practices. These include:

Scientific Opinion on sheep pox and goat pox - first part

Parasitic Protozoa, Helminths, and Arthropod Vectors

The duration of protective immunity following immunisation is unknown, but is believed to be in excess of five years.

Communicable diseases. Gastrointestinal track infection. Sarkhell Araz MSc. Public health/epidemiology

2. According to the information provided by the WHO, there is no justification at this stage for restrictions on travel or trade.

IN VIVO STUDIES ON VIRAL VIRULENCE

Outbreak Scenario Based on an outbreak that occurred in the Netherlands

ANTHRAX (Malignant Edema, Malignant Pustule, Woolsorter's Disease, Charbon, Ragpicker's Disease)

MRA basic awareness course

Pathogenesis of Infectious Diseases. CLS 212: Medical Microbiology

July 1, 2005 Page 1 of 5

Campylobacter jejuni

OCCUPATIONAL HEALTH IMPLICATIONS: FROM LABORATORY TO FIELD

Anthrax. Department of Child Health Medical Faculty University of Sumatera Utara

Burton's Microbiology for the Health Sciences

TB Could Ruin Your Day (And Your Life)

species; Gram-positive or Gram-variable bacilli 60 (Large (0.5 x 1.2 to 2.5 x 10 um Most are saprophytic contaminants or normal flora

Wisconsin Department of Agriculture, Trade & Consumer Protection Division of Animal Health

Australia s Role on the Global Vaccine Stage

My presentation is about bovine neonatal diarrhea, more commonly referred to as calf scours. As always, good management is an important factor when

Housing of Different Infected Mice in the Same Room: How to Prevent Roommate Conflicts? Jocelyn Beaucher, PhD, microbiologist Biosafety Officer

Biosafety in the Animal Setting. Tina Bogac Institutional Biosafety Officer

Study Guide 23, 24 & 47

California Association for Medical Laboratory Technology

RHODOCOCCUS EQUI. Post-mortem Environmental Persistence Specific Control Measures Release of Animals from Isolation

Risk Factors for Q Fever in the Netherlands

Lecture (14) Amiedi Ph.D.Microbiology

Zoonosis = an infection or infestation which is shared in nature by man and lower vertebrate animals.

WYANDOT COUNTY 2016 COMMUNICABLE DISEASE REPORT

Welcome to Pathogen Group 4

Pathogens. How Do They Cause Disease?

BadBugBook FoodbornePathogenicMicroorganismsandNaturalToxins

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES

Detection of a Simulated Infectious Agent

Risk Assessment Report Listeria monocytogenes in foods

Section 1 - Short answer questions on knowledge of epidemiology terms and concepts. (Each question is worth 2 points)

Data collection on African Swine Fever virus for epidemiological analysis. Claire Guinat EFSA Worshop, Parma, Italy 2015

Preventing & Controlling the Spread of Infection

True Pathogens of the Enterobacteriaceae: Salmonella, Shigella & Yersinia Salmonella

Q fever through consumption of unpasteurised milk and milk products a risk profile and exposure assessment

A modelling programme on bio-incidents. Submitted by the United Kingdom

Introduction. Transmission

Epidemiology. Reservoir & Resources of Infectious Agent : Human Reservoir :

Supplemental Information Dose Response Parameters for Gain of Function Pathogens

Transcription:

Chapter 4 Coxiella burnetii 4. General overview of Coxiella burnetii and Q fever Coxiella burnetii (C. burnetii), an obligate intracellular gram-negative bacterium, is the causative agent of Q fever. C. burnetii multiplies only within the phagolysosomal vacuoles, particularly the macrophages of the host. During natural infections, the organism grows to high numbers in placental tissues of animals such as goats, sheep, and cows. The Center for Disease Control and Prevention (CDC) has classified C. burnetii as a category B biological terrorist agent because it consistently causes disability, can be manufactured on a large scale, remains stable under production, storage, and transportation conditions, can be efficiently disseminated and remains viable for years after dissemination. Q fever, a zoonotic disease found worldwide, may manifest as acute or chronic disease. The acute form is generally not fatal and manifests as self-controlled febrile illness. Chronic Q fever is usually characterized by endocarditis. Many animal models, including humans, have been studied for Q fever infection through various exposure routes. Humans are infected primarily through inhalation of aerosolized C. burnetii with as few as 0 organisms causing disease. Aerosols, or airborne particles, easily cause infection even without contact with infected animals, whereas person-to-person infection is rare. Ingestion of contaminated dairy products or bites from infected ticks may also lead to infection but these modes of transmission are very rare. However, there have been some recorded cases of human Q fever caused by the consumption of unpasteurized goat milk products (Tamrakar et al. 20). 4.2 Summary Data Williams and Cantrell (982) interperitoneally inoculated groups of C57BL/0ScN male mice with different doses of C. burnetii phase I Ohio strain to develop a vaccine against Q fever. Scott and Williams (987) examined the susceptibility of inbred mice to infection by C. burnetii Nine mile phase I strain. As many as 47 strains of inbred mice were evaluated. Groups of resistant C57BL/6J mice were inoculated with mean doses ranging from 0.3 to 0 7 organisms. The mortalities at various doses were recorded. 22

Table 4.. Summary of the Coxiella burnetii data and best fits Experiment number 2 Reference Williams et al., 982 Scott et al., 987 Host type/patho gen strain mice/ phase I Ohio strain mice/ Nine mile phase I strain Route / number of doses interperito neal/0 interperito neal/3 Dose unit No. of organis ms No. of organis ms Response death The data from different experiments were not able to be statistically pooled. Best-fit model Beta- Best-fit parameters α = 0.36 N 50 = 4.93E+08 4.93E+08 death Exponential K=5.70E-.22E+0 23

4.3 Optimized Models and Fitting Analyses 4.3. Optimization Output for experiment Table 4.2. Mice/ phase I Ohio strain model data Dose Dead Survived Total 7.00E+0 9 20 7.00E+09 23 7 30 7.00E+08 6 4 30 7.00E+07 6 24 30 7.00E+06 9 20 7.00E+05 0 30 30 7.00E+03 0 30 30 7.00E+0 0 30 30 7.00E+00 0 20 20 7.00E-0 0 30 30 Williams et al., 982. Table 4.3. Goodness of Fit and Model Selection Model Deviance DF Exponent ial Beta 73.87 72.76 9. 8 Beta is best fitting model χ 2 0.95, p- value 3.84 0 χ 2 0.95,m-k p-value 6.92 0 5.5 0.998 Table 4.4 Optimized parameters for the best fitting (beta ), obtained from 0,000 bootstrap iterations Parameter MLE Estimate Percentiles 0.5% 2.5% 5% 95% 97.5% 99.5% α 0.36 -- -- -- -- -- -- N 50 4.93E+08 -- -- -- -- -- -- (spores) 4.93E+08.9E+08 2.4E+08 2.73E+08 9.37E+08.08E+09.39E+09 Figure 4. Parameter scatter plot for beta model ellipses signify the 0.9, 0.95 and 0.99 confidence of the parameters. Figure 4.2 beta model plot, with confidence bounds around optimized model 24

4.3 Optimized Models and Fitting Analyses 4.3.2 Optimization Output for experiment 2 Table 4.5 Mice/ Nine mile phase I strain model data Dose Dead Survived Total 5.0E+0 9 0 5.0E+09 3 7 0 5.0E+08 9 0 5.0E+07 0 0 0 5.0E+06 0 0 0 5.0E+05 0 0 0 5.0E+04 0 0 0 5.0E+03 0 0 0 5.0E+02 0 0 0 5.00E+0 0 0 0 5.00E+00 0 0 0 5.00E-0 0 0 0 5.00E-02 0 0 0 Scott et al., 987. Table 4.6. Goodness of Fit and Model Selection Model Deviance DF Exponenti al Beta.63 0.94 2 0.69 Exponential is best fitting model χ 2 0.95, p- value 3.84 0.333 χ 2 0.95,m-k p-value 2.03 9.68 Table 4.7 Optimized parameters for the best fitting (exponential), obtained from 0,000 bootstrap iterations Parameter MLE Estimate Percentiles 0.5% 2.5% 5% 95% 97.5% 99.5% k 5.70E- 2.30E- 2.94E- 3.3E-.38E-0.56E-0 2.3E-0 (spores).22e+0 3.25E+09 4.45E+09 5.02E+09 2.09E+0 2.36E+0 3.02E+0 Figure 4.3 Parameter histogram for exponential model (uncertainty of the parameter) Figure 4.4 Exponential model plot, with confidence bounds around optimized model 25

4.4. Summary Noting an apparent difference of between the experiment (4.93x0 8 ) and experiment 2 (.22 x0 0 ) routes has been identified. This may reflect the difference of susceptibilities associated with different host and pathogen strains. References Scott, G. and J. C. Williams (987). "Pathological responses of inbred mice to phase I Coxiella Burnetii." Journal of General Microbiology 33(3): 69 700. Tamrakar, S. B., A. Haluska, C. N. Haas and T. A. Bartrand (20). "Dose-Response Model of Coxiella burnetii (Q Fever)." Risk Analysis 3(): 20-28. Williams, J. C. and J. L. Cantrell (982). "Biological and immunological properties of Coxiella burnetii vaccines in C57BL/OScN endotoxin-nonresponder mice." Infection and Immunity 35(3): 09 02. 26